Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-120055·Enveric Biosciences, Inc.
Schedule 13G ownership disclosure
ENVERIC BIOSCIENCES INC
Common Stock, $0.01 par value per share · CUSIP: 29405E505
Event date: 2025-12-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Northstrive Fund II LP
Shares: 0.00 · Class: 0%
- Braeden Lichti
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-120055
- Form type
- SCHEDULE 13G/A
- Filer
- Enveric Biosciences, Inc.
- CIK
- CIK 890821
- Filed
- Dec 10, 2025
- Reporting period
- Dec 09, 2025
- Description
- Schedule 13G beneficial ownership